Europe Just Became the #1 Destination for K-Beauty
In Q1 2026, Korean cosmetics exports to Europe surpassed the US for the first time. This isn't a trend. It's a structural shift — and most brands are still missing it.

The numbers first.
Europe: $675M in Korean cosmetics exports. +58% YoY. United States: $619M. +41% YoY.
For the first time in history, Europe overtook the US as the top destination for K-Beauty.
At Boots in the UK, one K-Beauty product sells every 15 seconds.
This isn't a seasonal blip. It's a structural shift.
Where the growth is concentrated.
Not all European markets are moving at the same speed.
Estonia: +281% United Kingdom: +161% Germany: +148% Netherlands: +137% Poland: +51%
The UK is scaling through pharmacy retail. Germany through Sephora flagship rollouts. The Netherlands is becoming a logistics hub for the whole region.
But here's what most brands miss.
This isn't just a demand story. It's a trust and distribution story.
The US playbook was: DTC first, Amazon next, virality carries you.
Europe doesn't work that way.
European consumers want to touch and try before they commit. Offline presence builds belief in the category. Accessibility — not virality — drives repeat purchases. Online and offline have to run simultaneously from day one.
The brands winning in Europe right now understand this.
The brands leading the playbook.
Beauty of Joseon entered UK pharmacy retail through Boots — 700+ stores. Mass-market scale built on trust, not ads.
Medicube went premium through Sephora in Germany and France. Positioning before performance.
Amorepacific is running a multi-market rollout across EU Sephora — a signal that the big players see this market as a long-term bet, not an experiment.
What this means if you're a K-Beauty brand.
If you're still thinking US-first only, it's worth reconsidering.
Europe isn't the "next market." It's the current opportunity — and the brands that enter now with the right distribution strategy will own shelf space, customer trust, and market share before the window closes.
The playbook is different from the US. The opportunity is just as big.
